1. Summary of Safety and Effectiveness for a Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.fda. gov/cdrh/pdf2/P020050b.pdf. Accessed February 2008.
2. Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.fda.gov/cdrh/pdf2/P020050S004b.pdf. Accessed February 2008.
3. Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (VISX Star S4 Excimer Laser System and WaveScan WaveFront System). Available at: http:// www.fda.gov/ohrms/dockets/dailys/04/july04/072004/03m-0333-cr00001-02-summaryofsafety-vol1.pdf. Accessed February 2008.
4. Bausch & Lomb Incorporated Technolas 217z Zyoptix System for Personalized Vision Correction. Available at: http://www. fda.gov/cdrh/pdf/P990027S006c.pdf. Accessed February 2008.
5. Contrast sensitivity after laser in situ keratomileusis;Perez-Santonja JJ;J Cataract Refract Surg.,1998